Neurology Minute show

Neurology Minute

Summary: The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Join Now to Subscribe to this Podcast

Podcasts:

 Antibody evaluation in optic neuritis | File Type: audio/mpeg | Duration: 02:08

Dr. David Lapides discusses the importance of early antibody evaluation in the setting of a new case of optic neuritis.

 Continuum Pearls: Disease-Modifying Therapies in MS | File Type: audio/mpeg | Duration: 01:39

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. 

 Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2 | File Type: audio/mpeg | Duration: 03:08

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. 

 Determining clinically meaningful decline in preclinical Alzheimer disease | File Type: audio/mpeg | Duration: 01:29

Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease. 

 Targeting Huntington Expression in Patients with Huntington’s Disease | File Type: audio/mpeg | Duration: 01:33

Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington’s Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article

 Continuum Pearls: Disease-Modifying Therapies in MS | File Type: audio/mpeg | Duration: 02:17

Dr. Rob H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. 

 Recent Minnesota Supreme Court decision | File Type: audio/mpeg | Duration: 01:41

Dr. David Lapides discusses a recent Minnesota Supreme Court decision that a patient-doctor relationship was not a necessary element of a claim for professional negligence.

 Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2 | File Type: audio/mpeg | Duration: 03:29

Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext. The study was also covered in Neurology Today, which you can read here: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2019&issue=03070&article=00004&type=FullText. 

 The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry | File Type: audio/mpeg | Duration: 02:05

Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. 

 Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial | File Type: audio/mpeg | Duration: 02:06

Prof. Gil Wolfe summarizes his findings from his study on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. Read the paper in Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext.  Additionally, see the Neurology Today article from March 7th featuring the study: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2019&issue=03070&article=00004&type=FullText. 

 Neurology Residency Programs & Training | File Type: audio/mpeg | Duration: 01:55

Dr. Jeffrey Ratliff discusses neurology residency programs, training, and action by the consortium of residency program directors.

 MuSK Myasthenia Gravis | File Type: audio/mpeg | Duration: 02:55

Dr. Ted Burns discusses clinical recognition and diagnosis of MuSK myasthenia gravis.

 Continuum Pearls: Pregnancy and Family Planning in Multiple Sclerosis, pt. 3 | File Type: audio/mpeg | Duration: 01:45

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the third of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. 

 Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease | File Type: audio/mpeg | Duration: 01:38

Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

 First Cannabis-Derived Pharmaceutical | File Type: audio/mpeg | Duration: 01:27

Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full article, "The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?" by Dr. Szaflarski in JAMA Neurology: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720. 

Comments

Login or signup comment.